PB2034: CAMMA 1: A MULTICENTER PHASE IB TRIAL EVALUATING THE SAFETY, PHARMACOKINETICS AND ACTIVITY OF CEVOSTAMAB-CONTAINING REGIMENS IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPL... по R. Vij, H. Schade, S. Trudel, A. C. Chang, J. Huang, D. Samineni, T. Sumiyoshi, J. Tsai, T. Wong, S. J. Harrison

Полный текст